Transarterial chemoembolization (TACE) is the most performed endovascular interventional radiology (IR) procedure. TACE procedures are performed in an IR suite, most of which are equipped with floor-based flat-panel robotic C-arm allowing two-dimensional imaging. Cone-beam computed tomography (CBCT) has been developed to allow three-dimensional navigation but has several limitations such as reduced signal to noise ratio and small field-of-view, and seems to have negative impact on patient radiation exposure. Another option to perform 3D imaging is called angio-CT which combines a CT-scan and a floor-based flat-panel robotic C-arm in a single IR suite. Even if some publications have shown benefit of angio-CT in TACE procedures in Japan, no study about angio-CT in liver IR procedures has been conducted in the occidental world so far. The purpose of our study was to assess the impact of angio-CT use on patient radiation exposure and treatment quality in TACE procedures compared to CBCT. This before-after study consisted of a review of consecutive TACE procedures performed between January 2016 and September 2017 in our institution with two different imaging modalities, defining two study groups (C-arm with CBCT versus angio-CT).
Study Type
OBSERVATIONAL
Enrollment
145
Uhmontpellier
Montpellier, France
Patient effective radiation dose per TACE
Patient effective radiation dose (mSv) per TACE : Dose-area product (in mGy/cm\^2) and dose-length product (in mGy/cm) will be combined and converted to report effective dose (in mSv).
Time frame: 1 day
Air kerma per TACE
Air kerma (in mGy) per TACE
Time frame: 1 day
Fluoroscopy time per TACE
Fluoroscopy time (in sec) per TACE
Time frame: 1 day
Number of CBCT acquisitions per TACE
Number of CBCT acquisitions per TACE
Time frame: 1 day
Number of CT acquisitions per TACE
Number of CT acquisitions per TACE
Time frame: 1 day
Treatment targeting
Assessed on control CBCT or CT and graded into 3 classes : fully targeted, partially targeted or untargeted.
Time frame: 1 day
Tumor response
Assessed on follow-up CT or MRI and graded into 3 classes : response, tumor stability or progression.
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.